A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test
NCT05634473 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280
Last updated 2022-12-02
Summary
A multicenter, open-label study to evaluate the sensitivity and specificity of inhaled methacholine in bronchial provocation test
Conditions
Interventions
- DRUG
-
Methacholine Chloride
Cholinergic agonists
Sponsors & Collaborators
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-12-31
- Primary Completion
- 2023-02-28
- Completion
- 2023-06-30
Countries
- China
Study Locations
More Related Trials
-
A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects
NCT05171348 ·Status: COMPLETED ·Phase: PHASE1
-
Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
NCT06775340 ·Status: RECRUITING ·Phase: PHASE2
-
Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma
NCT01617746 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA)
NCT01170429 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Two Methods of Bronchial Methacholine Provocation
NCT00503659 ·Status: COMPLETED ·Phase: NA
-
Prospective Clinical Study on the Clinical Efficacy and Prognostic Outcome of ICS/LABA Combined With Liqin Zhike Formula in the Treatment of Cough Variant Asthma
NCT07272278 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Phase I, Open-Label, Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide in Healthy Chinese Participants
NCT03276052 ·Status: COMPLETED ·Phase: PHASE1
-
Reversibility of Methacholine Induced Bronchoconstriction
NCT05977699 ·Status: COMPLETED ·Phase: PHASE4
-
Bronchodilating and Bronchoprotective Effects of Deep Inspirations
NCT01659476 ·Status: COMPLETED ·Phase: NA
-
A Trial of HBM9378 in Healthy Chinese Subjects
NCT05790694 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma
NCT04167280 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Clinical Trial of TQC2731 Injection
NCT04923607 ·Status: UNKNOWN ·Phase: PHASE1
-
Sphingosine-1-phosphate in Asthma
NCT04134351 ·Status: UNKNOWN ·Phase: NA
-
A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
NCT06422663 ·Status: COMPLETED
-
Single Ascending Dose Study of CM326 in Healthy Volunteers
NCT04842201 ·Status: COMPLETED ·Phase: PHASE1
-
Methacholine Challenge: Comparison of Doubling and Quadrupling Methacholine Dose Regimes Using the Tidal Volume Method
NCT00890539 ·Status: COMPLETED ·Phase: NA
-
Measurement of Exhaled Nitric Oxide (NO) and Bronchial Provocation Test With Mannitol as a Predictor of Response to Inhaled Corticosteroids in Chronic Cough
NCT00916526 ·Status: COMPLETED ·Phase: NA
-
Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma
NCT06940700 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of Fluticasone Furoate on Methacholine Challenge
NCT03898466 ·Status: COMPLETED ·Phase: PHASE4
-
Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness
NCT00605410 ·Status: COMPLETED ·Phase: PHASE4
-
Non-interventional Retrospective Multicenter Study of Patients With Bronchial Asthma During a Routine Visit to Out of Patients' Clinics
NCT01273363 ·Status: COMPLETED
-
Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma
NCT01725360 ·Status: COMPLETED ·Phase: PHASE4
-
Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough
NCT02303600 ·Status: UNKNOWN ·Phase: NA
-
A Phase Ib Study of RC1416 Injection
NCT06911866 ·Status: COMPLETED ·Phase: PHASE1